• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION 6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION 6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Code Activation, Positioning or Separation Problem (2906)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/23/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Implanted date: device was not implanted.Explanted date: device was not explanted.The actual device was not returned for evaluation.The investigation is currently ongoing.A follow up report will be submitted once the investigation is complete.A review of the device history record of the product code/lot# combination was conducted with no findings.
 
Event or Problem Description
The user facility reported that the angio-seal evolution device deployment failed.The patient was in good condition.There was no patient injury, medical/surgical intervention required.Additional information was received on 30september2020: a pre deployment angiogram was performed.No equipment or other devices used with the reported product.Patient condition was stable.Hemostasis was achieved with manual compression.Additional information was received on 01october2020: there were no other devices or equipment used with the reported product.
 
Additional Manufacturer Narrative
This report is being submitted as follow up no.1 to provide the completed investigation results.The actual device was not returned; therefore, an evaluation of the actual device was unable to be conducted.With no return of the actual device, the exact cause of the reported event cannot be definitively determined based on the available information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US
Common Device Name
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
265 davidson ave
suite 320
somerset NJ 08873
MDR Report Key10686518
Report Number3013394970-2020-00648
Device Sequence Number303985
Product Code MGB
UDI-Device Identifier00389701011783
UDI-Public00389701011783
Combination Product (Y/N)N
PMA/510(K) Number
P930038
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2020
Device Model NumberN/A
Device Catalogue NumberC610134
Device Lot Number06099541
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 09/23/2020
Supplement Date Received by Manufacturer11/10/2020
Initial Report FDA Received Date10/15/2020
Supplement Report FDA Received Date11/11/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-